The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Amoroso Michael since 2021.
This trader's CIK number is 1830874.
At the time of last reporting, Amoroso Michael was the President and CEO of Precision Biosciences Inc. (stock ticker symbol DTIL).
Also see all insider trading activities at Precision Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ABEO | 0 | $0 | 1,935 | $5,787 | 0 | $0 |
| 2021 | ABEO | 0 | $0 | 90,818 | $134,318 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DTIL | 0 | $0 | 37,802 | $177,392 | 118,805 | $0 |
| 2024 | DTIL | 0 | $0 | 141,928 | $89,876 | 279,580 | $0 |
| 2023 | DTIL | 0 | $0 | 172,024 | $88,549 | 385,925 | $0 |
| 2022 | DTIL | 0 | $0 | 11,006 | $14,527 | 24,208 | $0 |
1. Abeona Therapeutics Inc. (ABEO)
2. Precision Biosciences Inc (DTIL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-20 | ABEO | Sale | 327 | 3.90 | 1,275 |
| 2023-06-20 | ABEO | Sale | 338 | 4.45 | 1,504 |
| 2023-03-20 | ABEO | Sale | 268 | 2.33 | 624 |
| 2023-03-03 | ABEO | Sale | 1,002 | 2.38 | 2,384 |
| 2021-09-30 | ABEO | Sale | 45,409 | 1.09 | 49,404 |
| 2021-03-31 | ABEO | Sale | 45,409 | 1.87 | 84,914 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-24 | DTIL | Sale | 964 | 5.56 | 5,359 |
| 2025-03-21 | DTIL | Option Ex | 3,417 | .00 | 0 |
| 2025-01-20 | DTIL | Option Ex | 115,388 | .00 | 0 |
| 2025-01-21 | DTIL | Sale | 36,838 | 4.67 | 172,033 |
| 2024-11-04 | DTIL | Sale | 3,012 | 8.19 | 24,668 |
| 2024-11-02 | DTIL | Option Ex | 9,443 | .00 | 0 |
| 2024-05-02 | DTIL | Sale | 1,526 | 10.32 | 15,748 |
| 2024-05-01 | DTIL | Option Ex | 3,417 | .00 | 0 |
| 2024-01-20 | DTIL | Option Ex | 266,720 | .00 | 0 |
| 2024-01-22 | DTIL | Sale | 137,390 | .36 | 49,460 |
| 2023-11-02 | DTIL | Option Ex | 283,390 | .00 | 0 |
| 2023-11-03 | DTIL | Sale | 125,025 | .40 | 50,010 |
| 2023-03-21 | DTIL | Option Ex | 102,535 | .00 | 0 |
| 2023-03-22 | DTIL | Sale | 46,999 | .82 | 38,539 |
| 2022-10-15 | DTIL | Option Ex | 24,208 | .00 | 0 |
| 2022-10-17 | DTIL | Sale | 11,006 | 1.32 | 14,527 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Amoroso Michael (President and CEO of Precision Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.